News from Eli Lilly and Company Limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

20 Apr, 2017, 11:35 ET Lilly to Present Data for Galcanezumab for the Prevention of Migraine at the American Academy of Neurology (AAN) Annual Meeting

Eli Lilly and Company (NYSE: LLY) will highlight Phase 2 data evaluating galcanezumab for the prevention of migraine at the American Academy of...


14 Apr, 2017, 09:00 ET U.S. FDA Issues Complete Response Letter for Baricitinib

Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has issued...


11 Apr, 2017, 11:00 ET Lilly Confirms Date and Conference Call for First-Quarter 2017 Financial Results Announcement

Eli Lilly and Company (NYSE: LLY) will announce its financial results for the first quarter of 2017 on Tuesday, April 25, 2017. Lilly will also...


07 Apr, 2017, 10:00 ET Life with Type 1 Diabetes Made a Little Easier through Lilly Diabetes Scholarship Donations for Camps, College and Conferences

Living with type 1 diabetes comes with many unique challenges in all stages of life. For parents of children with the condition, financial, medical...


04 Apr, 2017, 13:00 ET Lilly and Ohio University Heritage College of Osteopathic Medicine Partner on Rotation Program for Medical Students

Students from Ohio University's Heritage College of Osteopathic Medicine will soon join Eli Lilly and Company's (NYSE: LLY) innovative rotation...


24 Mar, 2017, 08:00 ET Lilly Announces $850 Million Investment in U.S. Capital Projects in 2017

Eli Lilly and Company (NYSE: LLY) today announced plans to invest $850 million in its U.S. operations in 2017. The company's investments span...


23 Mar, 2017, 12:00 ET Lilly and the William Sansum Diabetes Center announce a five-year research collaboration

Eli Lilly and Company (NYSE: LLY) and the William Sansum Diabetes Center have established a research collaboration to improve the lives of Latino...


20 Mar, 2017, 06:45 ET Lilly Announces Phase 3 MONARCH 2 Breast Cancer Study of Abemaciclib Met Primary Endpoint of Progression-Free Survival

Eli Lilly and Company (NYSE: LLY) today announced that its MONARCH 2 trial of abemaciclib met the primary endpoint of progression-free survival...


04 Mar, 2017, 09:20 ET New Head-to-Head Data Shows Significantly Higher Response Rates for Lilly's Taltz® (ixekizumab) Compared to Stelara® (ustekinumab) in Patients with Moderate-to-Severe Plaque Psoriasis

Lilly to present head-to-head 24-week data comparing the efficacy and safety of Taltz and Stelara for the treatment of moderate-to-severe plaque...


03 Mar, 2017, 14:45 ET Lilly Diabetes Becomes 'Official Diabetes Health Partner of NASCAR®'

NASCAR® and Lilly Diabetes announced today that Lilly is expanding its involvement in NASCAR with a multi-year official partnership with the...


02 Mar, 2017, 06:45 ET Lilly Announces Changes in Senior Management

Eli Lilly and Company (NYSE: LLY) today announced changes in its executive committee. - Johna Norton will be promoted to senior vice...


01 Mar, 2017, 08:45 ET Lilly Completes Acquisition of CoLucid Pharmaceuticals

Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of CoLucid Pharmaceuticals, Inc. (NASD:CLCD). The...


28 Feb, 2017, 09:00 ET Lilly to Present New Data for Taltz® (ixekizumab) in Psoriasis and Psoriatic Arthritis at the American Academy of Dermatology (AAD) Annual Meeting

Eli Lilly and Company (NYSE: LLY) will highlight new Phase 3 data evaluating Taltz® (ixekizumab) for the treatment of moderate-to-severe plaque...


15 Feb, 2017, 17:56 ET Additional results from pivotal RA-BEAM study published in New England Journal of Medicine show baricitinib-treated patients demonstrated sustained improvement in rheumatoid arthritis compared to adalimumab and placebo

Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today additional detailed results from RA-BEAM – a pivotal phase...


09 Feb, 2017, 13:00 ET Lilly To Present At Leerink Partners Global Healthcare Conference

Eli Lilly and Company (NYSE: LLY) will present at the Leerink Partners Global Healthcare Conference on Thursday, February 16, 2017. Enrique...


09 Feb, 2017, 06:45 ET Carolyn R. Bertozzi, Ph.D., Elected to Lilly Board of Directors

The board of directors of Eli Lilly and Company (NYSE: LLY) has elected Carolyn R. Bertozzi, Ph.D., as a new member, effective Feb. 10, 2017. As a...


08 Feb, 2017, 16:00 ET Lilly to Present at Cowen Health Care Conference

Eli Lilly and Company (NYSE: LLY) will present at the Cowen and Company 37th Annual Health Care Conference on Tuesday, March 7, 2017. David A....


08 Feb, 2017, 06:45 ET Lilly's Trulicity® (dulaglutide) Label Updated to Include Use in Combination with Basal Insulin for Adults with Type 2 Diabetes

The label for Eli Lilly and Company's (NYSE: LLY) once-weekly Trulicity® (dulaglutide) is now updated to include use in combination with basal...


02 Feb, 2017, 09:00 ET Japan IP High Court Rules In Lilly's Favor On Alimta Vitamin Regimen Patents

Eli Lilly and Company (NYSE: LLY) today announced that the Japan IP High Court confirmed the decisions of the Japan Patent Office and ruled in...


31 Jan, 2017, 06:25 ET Lilly Reports Fourth-Quarter and Full-Year 2016 Results

Eli Lilly and Company (NYSE: LLY) today announced financial results for the fourth quarter and full year of 2016....


30 Jan, 2017, 12:00 ET Lilly Revises Time for Conference Call for Fourth-Quarter 2016 Financial Results Announcement

Eli Lilly and Company (NYSE: LLY) will host a call for investors, media and the general public at 11:30 a.m. Eastern Time on January 31, 2017 to...


18 Jan, 2017, 06:45 ET Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid

Eli Lilly and Company (NYSE: LLY) and CoLucid Pharmaceuticals, Inc. (NASD: CLCD) today announced an agreement for Lilly to acquire CoLucid for...


13 Jan, 2017, 16:51 ET U.S. FDA Extends Review Period for Baricitinib, an Investigational Rheumatoid Arthritis Treatment

Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has...


12 Jan, 2017, 11:05 ET U.S. Court of Appeals Rules In Lilly's Favor On Alimta Vitamin Regimen Patent

Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Court of Appeals for the Federal Circuit has upheld the district court's decision...


11 Jan, 2017, 06:45 ET Lilly and Merck Expand Immuno-Oncology Collaboration

Eli Lilly and Company (NYSE: LLY) today announced the expansion of an existing immuno-oncology collaboration with Merck, known as MSD outside the...